GlobeStar Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GlobeStar Therapeutics generated cash of -$205,760, which is more than the previous year. Cash used in financing activities reached the amount of $199,395 last year. Net change in cash is therefore -$6,365.
Cash Flow
| 2014 | -311.00K | -139.81K | 324.28K |
|---|---|---|---|
| 2015 | -402.45K | -14.26K | 421.19K |
| 2016 | -29.99K | 5.69K | 30.15K |
| 2017 | -53.74K | 0 | 62K |
| 2018 | -180.09K | -1.41K | 259K |
| 2019 | -260.13K | 0 | 269K |
| 2020 | -239.73K | -1.78K | 222.5K |
| 2021 | -751.23K | 0 | 675.75K |
| 2022 | -326.99K | 0 | 327.4K |
| 2023 | -205.76K | 0 | 199.39K |
GSTC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.36K | 5.96K | 81.44K | 100.45K | 91.59K | 14.1K | 5.84K | 0 | 1.21K | 127.74K |
Operating activities | ||||||||||
Net income | -1.94M | -1.48M | -9.80M | -541.73K | -675.07K | -816.74K | -1.67M | -3.29M | -1.08M | -1.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 54.66K | 1.27K | 1.32K | 472 | 118 | 508.44K | 0 | 22.12K | 689.79K |
Stock-based compensation expense | 1.26M | 509.19K | 8.13M | 35.5K | 68.25K | 0 | 307.71K | 0 | 0 | 0 |
| Deferred income tax benefit | 1.26M | 509.19K | 8.13M | 35.5K | 68.25K | 0 | 307.71K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.68K | 11.09K | -5.43K |
Inventories | 0 | 0 | 0 | 36 | -36.3K | -3.81K | 0 | 0 | 0 | 0 |
Accounts payable | 435.08K | 432.42K | 203.53K | -6.6K | 8.52K | 188.08K | 84.96K | 0 | 25.27K | 132.31K |
Cash generated by operating activities | -205.76K | -326.99K | -751.23K | -239.73K | -260.13K | -180.09K | -53.74K | -29.99K | -402.45K | -311.00K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -35K |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -1.78K | 0 | -1.41K | 0 | 0 | -14.26K | -104.81K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.69K | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | -1.78K | 0 | -1.41K | 0 | 5.69K | -14.26K | -139.81K |
Financing activities | ||||||||||
Common Stock Issued | 72.5K | 5K | 580.75K | 500 | 340.26K | 109.18K | 30K | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -1.6M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -269K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 55K | 0 | -95K | -222K | 269K | -259K | 20K | 0 | 0 | 0 |
Cash used in financing activities | 199.39K | 327.4K | 675.75K | 222.5K | 269K | 259K | 62K | 30.15K | 421.19K | 324.28K |
Net Change In Cash | -6.36K | 405 | -75.48K | -19.01K | 8.86K | 77.49K | 8.25K | 5.84K | 4.47K | -126.53K |
Cash at end of period | 0 | 6.36K | 5.96K | 81.44K | 100.45K | 91.59K | 14.1K | 5.84K | 5.68K | 1.21K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |